IP Library › Granted Patent US 10,016,525
Granted Patent B2
US 10,016,525 · App. 14/720,388 · Granted Jul 10, 2018

Antimicrobial compositions for use in wound care products

Inventors: Lori L. Adams (Tucson, AZ); Nicholas R. Krasnow (Tucson, AZ); Anoop Agrawai (Tucson, AZ); Donald R. Uhlmann (Tucson, AZ)
Assignee: Agienic, Inc.
A61L15/46A01N59/20A61K8/0279A61K8/0283A61K8/20A61K8/25A61K8/736A61K33/18A61K33/34A61L15/18A61L26/0066A61Q3/02A61Q17/005C09D5/14C09K8/524C09K8/54A61K2800/412A61L2300/102A61L2300/106A61L2300/404A61L2400/12C08K3/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,016,525
App. No.
14/720,388
Granted
Jul 10, 2018
Kind
B2
Abstract

Compositions having antimicrobial activity contain surface functionalized particles comprising an inorganic copper salt which has low water solubility. These types of inorganic salts may also be introduced in porous particles to yield antimicrobial compositions. The compositions may optionally comprise additional antimicrobial agents, salts with high water solubility, organic acids, salts of organic acids and their esters. The above compositions can be incorporated in a variety of wound care products to provide antimicrobial properties.

Claims (21)

1. An antimicrobial wound care bandage product having a copper releasing composition comprising:

(a) copper releasing particles of a copper halide with water solubility at room temperature of less than about 100 mg/liter,

wherein the surfaces of said particles are modified by at least one functionalizing agent; and

(b) at least one material selected from an organic acid or a salt of an organic acid, and wherein the pH of the copper releasing composition is in the range between about 3 and about 6.

2. The antimicrobial wound care product as in claim 1 , wherein the said copper halide is cuprous iodide.

3. The antimicrobial wound care product as in claim 1 , wherein the average size of the said particles is below 1,000 nm.

4. The antimicrobial wound care product as in claim 1 , wherein the molecular weight of the said functionalization agent is at least 60.

5. The antimicrobial wound care product as in claim 1 , wherein the salt of the organic acid comprises a cation selected from the group consisting of lithium, sodium, potassium, calcium, copper, zinc and silver.

6. The antimicrobial wound care product as in claim 1 , wherein the composition further contains at least one of an additional antimicrobial agent, antibiotic, anti-fungal agent, anti-thrombogenic agent, anesthetic, anti-inflammatory agent, analgesic, anticancer agent, vasodilation substance, wound healing agent, angiogenic control agent, antipruritic agent, immune boosting agent and a nutrient.

7. An antimicrobial wound care bandage product having a copper releasing composition comprising:

(a) copper releasing particles containing CuI;

(b) an acid selected from at least one of hydroxy acid, amino acid, acetic acid, erythorbic acid, and hyaluronic acid;

(c) a material selected from at least one of a salt or an ester of an organic acid; and

(d) the pH of the composition in the range between about 3 and about 6.

8. An antimicrobial wound care bandage product having a copper releasing composition comprising:

copper-releasing particles containing copper halide with a water solubility at room temperature of less than about 100 mg/liter,

wherein the surfaces of the copper-releasing particles are modified by at least one functionalizing agent, and

wherein the pH of the said composition is between about 3 and about 6.

9. The antimicrobial wound care product as in claim 8 , wherein said halide is cuprous iodide.

10. The antimicrobial wound care product as in claim 7 , wherein the concentration of CuI in said product is at or below 5 weight %.

11. The antimicrobial wound care product as in claim 8 , wherein the concentration of copper halide in said product is at or below 5 weight %.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2015
From: ADAMS, LORI; KRASNOW, NICHOLAS; AGRAWAL, ANOOP; UHLMANN, DONALD
To: AGIENIC, INC.
Reel/Frame 035702/0130 →
Continuity (9)
Continuation In Part 14089146 · Nov 25, 2013
Continuation In Part 13685379 · Nov 26, 2012
Continuation In Part 13480367 · May 24, 2012
Provisional Application 61800122 · Mar 15, 2013
Provisional Application 61820561 · May 7, 2013
Provisional Application 61881318 · Sep 23, 2013
Provisional Application 61582322 · Dec 31, 2011
Provisional Application 61519523 · May 24, 2011
Related Publication 20160220728A1 · Aug 4, 2016
Cited By (1)
US 12,703,802